BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 34080543)

  • 1. Rural and small metro area naloxone-dispensing pharmacists' attitudes, experiences, and support for a frontline public health pharmacy role to increase naloxone uptake in New York State, 2019.
    Tofighi B; Lekas HM; Williams SZ; Martino D; Blau C; Lewis CF
    J Subst Abuse Treat; 2021 Oct; 129():108372. PubMed ID: 34080543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist attitudes and provision of harm reduction services in North Carolina: an exploratory study.
    Parry RA; Zule WA; Hurt CB; Evon DM; Rhea SK; Carpenter DM
    Harm Reduct J; 2021 Jul; 18(1):70. PubMed ID: 34238306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama.
    Sisson ML; McMahan KB; Chichester KR; Galbraith JW; Cropsey KL
    Int J Drug Policy; 2019 Dec; 74():229-235. PubMed ID: 31698165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacists' and technicians' perceptions and attitudes toward dispensing buprenorphine/ naloxone to patients with opioid dependence.
    Raisch DW; Fudala PJ; Saxon AJ; Walsh R; Casadonte P; Ling W; Johnson BA; Malkerneker U; Ordorica P; Williford WO; Sather MR
    J Am Pharm Assoc (2003); 2005; 45(1):23-32. PubMed ID: 15730114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparing pharmacists to increase naloxone dispensing within community pharmacies under the Pennsylvania standing order.
    Santa HM; Amirova SG; Ventricelli DJ; Downs GE; Nowalk AA; Pringle JL; Aruru M
    Am J Health Syst Pharm; 2021 Feb; 78(4):327-335. PubMed ID: 33336254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent community pharmacists' attitudes and intentions toward dispensing buprenorphine/naloxone for opioid use disorder.
    Zalmai R; Hill LG; Loera LJ; Mosgrove Q; Brown C
    J Am Pharm Assoc (2003); 2023; 63(5):1558-1565.e4. PubMed ID: 37331654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacists' experiences with a statewide naloxone standing order program in Massachusetts: a mixed methods study.
    Pollini RA; Slocum S; Ozga J; Joyce R; Xuan Z; Green TC; Walley AY
    J Am Pharm Assoc (2003); 2022; 62(1):157-166. PubMed ID: 34511372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists' naloxone services beyond community pharmacy settings: A systematic review.
    Rawal S; Osae SP; Cobran EK; Albert A; Young HN
    Res Social Adm Pharm; 2023 Feb; 19(2):243-265. PubMed ID: 36156267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacists and Naloxone: Barriers to Dispensing and Effectiveness of an Educational Outreach Program.
    Hanson KA; Smart MH; Mandava MR; Carkovic E; Aslamy M; Lee TA; Pickard AS
    J Am Pharm Assoc (2003); 2023; 63(2):608-613.e3. PubMed ID: 36631342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using the behaviour change wheel to understand and address barriers to pharmacy naloxone supply in Australia.
    Nielsen S; Olsen A
    Int J Drug Policy; 2021 Apr; 90():103061. PubMed ID: 33321285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia.
    Thornton JD; Lyvers E; Scott VGG; Dwibedi N
    J Am Pharm Assoc (2003); 2017; 57(2S):S12-S18.e4. PubMed ID: 28163027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "I go out of my way to give them an extra smile now:" A study of pharmacists who participated in Respond to Prevent, a community pharmacy intervention to accelerate provision of harm reduction materials.
    Irwin AN; Gray M; Ventricelli D; Boggis JS; Bratberg J; Floyd AS; Silcox J; Hartung DM; Green TC
    Res Social Adm Pharm; 2024 May; 20(5):512-519. PubMed ID: 38395644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016.
    Meyerson BE; Agley JD; Davis A; Jayawardene W; Hoss A; Shannon DJ; Ryder PT; Ritchie K; Gassman R
    Drug Alcohol Depend; 2018 Jul; 188():187-192. PubMed ID: 29778772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers and facilitators to dispensing of intranasal naloxone by pharmacists.
    Bakhireva LN; Bautista A; Cano S; Shrestha S; Bachyrycz AM; Cruz TH
    Subst Abus; 2018; 39(3):331-341. PubMed ID: 29043922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states.
    Green TC; Case P; Fiske H; Baird J; Cabral S; Burstein D; Schwartz V; Potter N; Walley AY; Bratberg J
    J Am Pharm Assoc (2003); 2017; 57(2S):S19-S27.e4. PubMed ID: 28214219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacists' role in opioid overdose: Kentucky pharmacists' willingness to participate in naloxone dispensing.
    Freeman PR; Goodin A; Troske S; Strahl A; Fallin A; Green TC
    J Am Pharm Assoc (2003); 2017; 57(2S):S28-S33. PubMed ID: 28139459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Like it was just everyday business": A qualitative study of pharmacy-based naloxone and syringe customer experience.
    Gray M; Shin SS; Silcox J; Flores D; Bolivar D; Irwin AN; Floyd AS; Bratberg J; Boggis JS; Hartung DM; Green TC
    J Am Pharm Assoc (2003); 2023; 63(3):838-846. PubMed ID: 36872182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacist attitudes toward pharmacy-based naloxone: A cross-sectional survey study.
    Burstein D; Baird J; Bratberg J; Donovan E; Soipe A; Tapper A; Case P; Walley AY; Green TC
    J Am Pharm Assoc (2003); 2020; 60(2):304-310. PubMed ID: 31870862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual- and neighborhood-level characteristics associated with support of in-pharmacy vaccination among ESAP-registered pharmacies: pharmacists' role in reducing racial/ethnic disparities in influenza vaccinations in New York City.
    Crawford ND; Blaney S; Amesty S; Rivera AV; Turner AK; Ompad DC; Fuller CM
    J Urban Health; 2011 Feb; 88(1):176-85. PubMed ID: 21279450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying barriers to dispensing naloxone: A survey of community pharmacists in North Carolina.
    Rudolph SE; Branham AR; Rhodes LA; Hayes HH; Moose JS; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S55-S58.e3. PubMed ID: 30006187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.